NeuroMetrix, Inc. (NURO) financial statements (2021 and earlier)

Company profile

Business Address 1000 WINTER STREET
WALTHAM, MA 02451
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments37441299
Cash and cash equivalents37441299
Receivables0111110
Inventory, net of allowances, customer advances and progress billings1311111
Inventory1311111
Deferred costs  21   
Other undisclosed current assets1111110
Total current assets:51298151111
Noncurrent Assets
Operating lease, right-of-use asset1
Property, plant and equipment0001100
Other undisclosed noncurrent assets0000000
Total noncurrent assets:1001100
TOTAL ASSETS:712108161111
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2343332
Accounts payable1111110
Accrued liabilities1222111
Employee-related liabilities  10110
Taxes payable     00
Debt1      
Deferred revenue and credits  000
Other undisclosed current liabilities1311 (0)(0)
Total current liabilities:3653332
Noncurrent Liabilities
Long-term debt and lease obligation1      
Operating lease, liability1
Liabilities, other than long-term debt     00
Deferred revenue and credits   00
Other undisclosed noncurrent liabilities   0052
Total noncurrent liabilities:1  0052
Total liabilities:4653384
Stockholders' equity
Stockholders' equity attributable to parent, including:36551337
Common stock0000000
Additional paid in capital197197196183176158154
Accumulated deficit(195)(191)(191)(178)(164)(154)(147)
Other undisclosed stockholders' equity attributable to parent000000 
Total stockholders' equity:36551337
TOTAL LIABILITIES AND EQUITY:712108161111

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues9161712765
Other operating income 12     
Cost of revenue(7)(9)(10)(7)(4)(3)(2)
Cost of goods and services sold(3)     (0)
Gross profit:2775333
Operating expenses(14)(20)(20)(20)(17)(12)(10)
Operating loss:(12)(12)(13)(15)(13)(9)(7)
Nonoperating income (expense)8    (0)(0)
Other nonoperating income (expense)8    (0)(0)
Loss before gain (loss) on sale of properties:(4)(12)(13)(15)(13)(9)(8)
Other undisclosed net income 12     
Net income (loss):(4)0(13)(15)(13)(9)(8)
Other undisclosed net income (loss) attributable to parent  0041(0)
Net income (loss) attributable to parent:(4)0(13)(15)(9)(8)(8)
Preferred stock dividends and other adjustments  (7)(20)   
Other undisclosed net loss available to common stockholders, basic    (12)(3)(1)
Net income (loss) available to common stockholders, diluted:(4)0(20)(35)(21)(11)(9)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):(4)0(13)(15)(13)(9)(8)
Comprehensive income (loss), net of tax, attributable to parent:(4)0(13)(15)(13)(9)(8)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: